Cancer mortality in the United States has declined by about 1.5% per year since 1999.1,2 Patients with most of the common solid tumors have experienced decreased mortality risk over this period, including those with breast cancer, in whom mortality fell by 1.8% per year between 1998 and 2016.2 Although there is much to celebrate in these statistics, there is still a long way to go. Breast cancer remains the second leading cause of cancer death among US women, with an estimated 42 000 deaths in 2018. At this rate, it would take 80 years for breast cancer mortality to fall to less than 10 000 women per year.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Armstrong KA. Maximizing the Outcomes of Breast Cancer Prevention. JAMA Intern Med. 2019;179(12):1621–1623. doi:10.1001/jamainternmed.2019.4666
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.